Winner

Healthcare - Emerging Corporates

Award Function

  • B0367_2015_0 B0367_2015_0
CMPOne Day(%)Weekly(%)Monthly(%)Quarterly(%)Half Yearly(%)Year(%)YTD(%)52 Weeks High52 Weeks Low
672 -38.61 -38.61 -38.61 -38.61 -38.61 -38.61 -38.61
* Not adjusted for Corporate Action i.e. Bonus / Split / Dividend
Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
22-Oct-18 Motilal Oswal Positive Committee opinion Neutral 658 625 -5.02
24-Sep-18 Motilal Oswal Favorable regulatory outcome enhances biosimilars prospects Buy 665 625 -6.02
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612
3-Dec-17 Motilal Oswal Mylan/ Biocon received Trastuzumab approval in US Neutral 447 485 8.5
27-Oct-17 Nirmal Bang Sec Slowdown In Biosimilar Business As Well As Licensing Income Sell 360 308 -14.44


Analyst Calls / Meets


Management Interviews

24-Dec-18 Kiran Mazumdar ..  
12-Nov-18 Kiran Mazumdar ..  
26-Oct-18 Kiran Mazumdar ..  
27-Apr-18 Kiran Mazumdar ..  
20-Jan-18 Kiran Mazumdar ..  

Investor Presentations

16-Nov-18 Investor/Anal...
31-May-18 Investor/Anal...
30-Jun-17 Investor/Anal...
28-Apr-17 Investor/Anal...
01-Feb-17 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2017-18  
2016-17  
2015-16  
2014-15  
2013-14  

Research Showcase

22-Oct-18
Motilal Oswal -..
Download
24-Sep-18
Motilal Oswal -..
Download
11-Apr-18
SPA Securities ..
Download
03-Dec-17
Motilal Oswal -..
Download
27-Oct-17
Nirmal Bang Sec..
Download

Results

25-Oct-18 Results
27-Jul-18 Results
27-Apr-18 Results
24-Jan-18 Results
27-Jul-17 Results

AGM/EGM/Board Meetings

24-Jan-19 - Quarterly Results
27-Jul-18 - AGM
08-Dec-17 - POM
26-Oct-17 - Quarterly Results
28-Jul-17 - AGM

RB Model Portfolio

17-Dec-18 HT230992 bought 20000  Shares
09-Nov-18 stock_rider bought 10000  Shares RB Model Portfolio
06-Nov-18 HT230992 bought 36822  Shares
26-Oct-18 HT230992 bought 20000  Shares
24-Sep-18 HT230992 bought 40000  Shares

Press Release

25-Oct-18 Press Release
19-Oct-18 Press Release
21-Sep-18 Press Release
18-Jan-18 Press Release
18-Jan-18 Press Release

 

Credit Ratings

12-Jan-17 Short-Term Rating ICRA A1+ Reaffirmed
12-Jan-17 Long-Term Rating [ICRA]AA+ (Stable) Reaffirmed
11-Aug-16 Short-Term Rating CRISIL A1+ Reaffirmed
11-Aug-16 Long-Term Rating CRISIL AA+/Stable Reaffirmed
08-Sep-15 Short-Term Rating ICRA A1+ Reaffirmed

Archived Documents

No Archieved Transcript.